Summary

for females ages 18-60 (full criteria)
healthy people welcome
at San Diego, California and other locations
study started
estimated completion:

Description

Summary

This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.

Keywords

Aneuploidy Trisomy 21 Trisomy 18 Trisomy 13 Down Syndrome amniocentesis chronic villus sampling Trisomy non-invasive prenatal testing Chromosome disorders

Eligibility

You can join if…

Open to females ages 18-60

    1. Subject is at least 18 years old and can provide informed consent;
    1. Subject has a viable singleton or twin pregnancy;
    1. Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the study blood draw;
    1. Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis and is known to have a fetus with a chromosomal abnormality confirmed by genetic analysis.

You CAN'T join if...

    1. Subject has known aneuploidy;
    1. Subject is pregnant with more than two fetuses or has had sonographic evidence of three or more gestational sacs at any time during pregnancy;
    1. Subject has a fetal demise (including natural or elective reduction) identified prior to consent;
    1. Subject has history of malignancy treated with chemotherapy and/or major surgery,or bone marrow transplant;

Locations

  • University California San Diego accepting new patients
    San Diego California United States
  • Regional Obestrical Consultants accepting new patients
    Chattanooga Tennessee 37403 United States
  • Women's Healthcare Group of PA completed
    Oaks Pennsylvania 19456 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Roche Sequencing Solutions
ID
NCT02201862
Study Type
Observational
Last Updated
July 2016